Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis
Authors
Keywords
-
Journal
JOURNAL OF HEADACHE AND PAIN
Volume 23, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-31
DOI
10.1186/s10194-022-01400-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)
- (2021) Biyan Nathanael Harapan et al. JOURNAL OF NEUROLOGY
- Virtual Issue: COVID‐19 and headache
- (2021) Sarah M. Bobker et al. HEADACHE
- Description of symptom course in a telemedicine monitoring clinic for acute symptomatic COVID-19: a retrospective cohort study
- (2021) James B O'Keefe et al. BMJ Open
- COVID‐19 Vaccine‐associated Immune Thrombosis and Thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome
- (2021) Massimo Franchini et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China
- (2021) Mei-Xian Zhang et al. Expert Review of Vaccines
- Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers
- (2021) Renuka A.K. Kadali et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- BNT162b2 vaccination in heart transplant recipients: clinical experience and antibody response
- (2021) Yael Peled et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution
- (2021) Fulvia Pimpinelli et al. Journal of Hematology & Oncology
- Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): a multicenter study
- (2021) Jitao Wang et al. JOURNAL OF HEPATOLOGY
- Non‐life‐threatening adverse effects with COVID‐19 mRNA‐1273 vaccine: A randomized, cross‐sectional study on healthcare workers with detailed self‐reported symptoms
- (2021) Renuka Ananth Kalyan Kadali et al. JOURNAL OF MEDICAL VIROLOGY
- Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
- (2021) Shilong Yang et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study
- (2021) Paul A Goepfert et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
- (2021) Keith J Chappell et al. LANCET INFECTIOUS DISEASES
- Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
- (2021) Cristina Menni et al. LANCET INFECTIOUS DISEASES
- COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
- (2021) Anat Achiron et al. Multiple Sclerosis Journal
- Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
- (2021) Brian J. Ward et al. NATURE MEDICINE
- Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared to healthy controls
- (2021) Benedikt Simon et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
- (2021) Tom T. Shimabukuro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Vivek Shinde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety survey by clinical pharmacists on COVID-19 vaccination from a single center in China
- (2021) Guangfei Wang et al. Human Vaccines & Immunotherapeutics
- Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic
- (2021) Abanoub Riad et al. Journal of Clinical Medicine
- Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database
- (2021) Mansour Tobaiqy et al. Vaccines
- The Incidence and Severity of Post-Vaccination Reactions after Vaccination against COVID-19
- (2021) Izabela Jęśkowiak et al. Vaccines
- Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium
- (2021) Sherry H.-Y. Chou et al. JAMA Network Open
- Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study
- (2021) Nagla A El-Shitany et al. International Journal of General Medicine
- Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV
- (2021) Jake A. Ruddy et al. AIDS
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
- (2021) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Maternal and Child Symptoms Following COVID-19 Vaccination Among Breastfeeding Mothers
- (2021) Skyler McLaurin-Jiang et al. Breastfeeding Medicine
- COVID-19-related headache and sinonasal inflammation: A longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection
- (2021) Marcin Straburzyński et al. CEPHALALGIA
- Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19
- (2021) Karl Messlinger et al. CEPHALALGIA
- The characteristics of COVID-19 vaccine-related headache: Clues gathered from the healthcare personnel in the pandemic
- (2021) Esme Ekizoglu et al. CEPHALALGIA
- Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study
- (2021) Koji Sekiguchi et al. CEPHALALGIA
- Immunogenicity and safety of a recombinant fusion protein vaccine (V-01) against coronavirus disease 2019 in healthy adults: a randomized, double-blind, placebo-controlled, phase II trial
- (2021) Ya-Jun Shu et al. CHINESE MEDICAL JOURNAL
- The effect of a single dose of BNT162b2 vaccine on the incidence of severe COVID-19 infection in patients on chronic hemodialysis: a single-centre study
- (2021) Gabor Cserep et al. Clinical and Experimental Nephrology
- Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study
- (2021) Miguel García-Grimshaw et al. CLINICAL IMMUNOLOGY
- Otolaryngology-Specific Symptoms May Be Highly Observed in Patients With a History of Covid-19 Infection After Inactivated Coronavirus Vaccination
- (2021) Hakan Avcı et al. ENT-EAR NOSE & THROAT JOURNAL
- COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center
- (2021) Randi von Wrede et al. EPILEPSY & BEHAVIOR
- Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel
- (2021) Itay Lotan et al. EUROPEAN JOURNAL OF NEUROLOGY
- Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March−June 2021, England
- (2021) Annabel A Powell et al. Eurosurveillance
- Adverse reactions to Pfizer‐BioNTech vaccination of healthcare workers at Malta's state hospital
- (2021) Sarah Cuschieri et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Myocarditis and Pericarditis After Vaccination for COVID-19
- (2021) George A. Diaz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults
- (2021) Nawal Al Kaabi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis
- (2021) David García-Azorín et al. JOURNAL OF HEADACHE AND PAIN
- Safety of COVID‐19 vaccines
- (2021) Qutaiba A. Al Khames Aga et al. JOURNAL OF MEDICAL VIROLOGY
- Side Effects after Second Dose of Covishield Vaccine among Health Care Workers: A Descriptive Cross Sectional Study
- (2021) Khilasa Pokharel et al. Journal of Nepal Medical Association
- Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
- (2021) Alberto M Borobia et al. LANCET
- Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
- (2021) Mine Durusu Tanriover et al. LANCET
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial
- (2021) Bihua Han et al. LANCET INFECTIOUS DISEASES
- A comprehensive analysis of the efficacy and safety of COVID-19 vaccines
- (2021) Changjing Cai et al. MOLECULAR THERAPY
- Underdiagnosis and undertreatment of migraine in Poland
- (2021) Olga P. Fermo Neurologia i Neurochirurgia Polska
- Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
- (2021) Robert W. Frenck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine-Induced Thrombocytopenia with Severe Headache
- (2021) Farid Salih et al. NEW ENGLAND JOURNAL OF MEDICINE
- ChAdOx1 COVID-19 vaccine-induced thrombocytopenia syndrome
- (2021) Y -H Wang et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey
- (2021) Somy Cherian et al. RHEUMATOLOGY INTERNATIONAL
- Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study
- (2021) Elena Campello et al. THROMBOSIS RESEARCH
- Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept
- (2021) Michael T. Ou et al. TRANSPLANTATION
- Short‐term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID ‐19 vaccine
- (2021) S. Bookstein Peretz et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease: A case control study
- (2021) Aurelie Baldolli et al. VACCINE
- Covid-19: Regulators warn that rare Guillain-Barré cases may link to J&J and AstraZeneca vaccines
- (2021) Owen Dyer BMJ-British Medical Journal
- Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients
- (2021) Cristina Bergamaschi et al. Cell Reports
- Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021
- (2021) Andrea Ossato et al. European Journal of Hospital Pharmacy-Science and Practice
- Subjective Feelings of Polish Doctors after Receiving the COVID-19 Vaccine
- (2021) Krzysztof Zdziarski et al. International Journal of Environmental Research and Public Health
- Can reactogenicity predict immunogenicity after COVID-19 vaccination?
- (2021) Young Hoon Hwang et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021
- (2021) Heather M. Scobie et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study among Healthcare Workers in Turkey
- (2021) Abanoub Riad et al. Journal of Clinical Medicine
- Pfizer-BioNTech COVID-19 Vaccine Tolerance in Allergic versus Non-Allergic Individuals
- (2021) Marita Nittner-Marszalska et al. Vaccines
- Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 Vaccines
- (2021) Osama Abu-Hammad et al. Vaccines
- Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection
- (2021) José Javier Morales-Núñez et al. Vaccines
- Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia
- (2021) Abdulaziz Alhazmi et al. Vaccines
- Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects
- (2021) Ma’mon M. Hatmal et al. Vaccines
- Impacts of Side Effects to BNT162b2 and the First Dose of ChAdOx1 anti-SARS-CoV-2 Vaccination on Work Productivity, the Need for Medical Attention, and Vaccine Acceptance: A Multicenter Survey on Healthcare Workers in Referral Teaching Hospitals in the Republic of Korea
- (2021) Tark Kim et al. Vaccines
- Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study
- (2021) Carl H. Göbel et al. Pain and Therapy
- Allergic Reactions After COVID-19 Vaccination—Putting Risk Into Perspective
- (2021) Elizabeth J. Phillips JAMA Network Open
- Survey data of COVID-19 vaccine side effects among hospital staff in a national referral hospital in Indonesia
- (2021) Dovy Djanas et al. Data in Brief
- Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in Japan
- (2021) Takehiro Izumo et al. Respiratory Investigation
- COVID-19 Vaccination among Spanish nephrologists: Results of survey on acceptance and side effects
- (2021) Borja Quiroga et al. Journal of Healthcare Quality Research
- Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research
- (2021) Edoardo Caronna et al. Current Pain and Headache Reports
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
- (2021) Sara Y Tartof et al. LANCET
- A snapshot global survey on side effects of COVID-19 vaccines among healthcare professionals and armed forces with a focus on headache
- (2021) Armando PERROTTA et al. PANMINERVA MEDICA
- Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms
- (2020) Abdul Mannan Baig et al. ACS Chemical Neuroscience
- Nervous system damage after COVID-19 infection: Presence or absence?
- (2020) Yeshun Wu et al. BRAIN BEHAVIOR AND IMMUNITY
- Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
- (2020) Claudio Liguori et al. BRAIN BEHAVIOR AND IMMUNITY
- COVID‐19 is a Real Headache!
- (2020) Hayrunnisa Bolay et al. HEADACHE
- Headache medication and the COVID-19 pandemic
- (2020) Antoinette MaassenVanDenBrink et al. JOURNAL OF HEADACHE AND PAIN
- Clinical and Epidemiological Characteristics of 1,420 European Patients with mild‐to‐moderate Coronavirus Disease 2019
- (2020) Jerome R. Lechien et al. JOURNAL OF INTERNAL MEDICINE
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis
- (2020) Israel Júnior Borges do Nascimento et al. Journal of Clinical Medicine
- Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes
- (2020) Shengli Xia et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
- (2020) Denis Y Logunov et al. LANCET
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- The arrival of Sputnik V
- (2020) Vijay Shankar Balakrishnan LANCET INFECTIOUS DISEASES
- Multiple Neuroinvasive Pathways in COVID-19
- (2020) Dmitri Bougakov et al. MOLECULAR NEUROBIOLOGY
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019
- (2020) T. J. Steiner et al. JOURNAL OF HEADACHE AND PAIN
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
- (2020) Catherine Collignon et al. Frontiers in Immunology
- Headache yesterday in Karnataka state, India: prevalence, impact and cost
- (2016) Timothy J. Steiner et al. JOURNAL OF HEADACHE AND PAIN
- Headache yesterday in Russia: its prevalence and impact, and their application in estimating the national burden attributable to headache disorders
- (2015) Ilya Ayzenberg et al. JOURNAL OF HEADACHE AND PAIN
- Lifetime prevalence and underdiagnosis of migraine in a population sample of Mexican women
- (2014) C Arroyo-Quiroz et al. CEPHALALGIA
- Headache yesterday in Europe
- (2014) Colette Andrée et al. JOURNAL OF HEADACHE AND PAIN
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
- Headache yesterday in China: A new approach to estimating the burden of headache, applied in a general-population survey in China
- (2013) Shengyuan Yu et al. CEPHALALGIA
- Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults
- (2013) Stéphanie Pépin et al. VACCINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started